FDA Clearance Tracker · P960013-S061
TENDRIL, TENDRIL ST, TENDRIL STS, AND OPTISENSE LEADS
Last checked: Nov 20, 2026Latest source record: Aug 13, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Aug 13, 2015
Approved
Time to decision
1,911 days
Received May 20, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960013-S061
- Device name
- TENDRIL, TENDRIL ST, TENDRIL STS, AND OPTISENSE LEADS
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- May 20, 2010
- Decided
- Aug 13, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Original approval
- P960013
Device type
- Device type
- Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MCRD AND STEROID COATING TEST METHODOLOGIES, SPECIFICATIONS, STABILITY PROTOCOLS AND OTHER MANUFACTURING PROCESSES TO MEET THE REQUIREMENTS IN THE AGREED UPON STEROID COMMITMENT LETTER.APPROVAL FOR MCRD AND STEROID COATING TEST METHODOLOGIES, SPECIFICATIONS, STABILITY PROTOCOLS AND OTHER MANUFACTURING PROCESSES TO MEET THE REQUIREMENTS IN THE AGREED UPON STEROID COMMITMENT LETTER.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.